25 completed, 11 terminated, 4 recruiting, 3 withdrawn. 14 Phase 4, 13 Phase 2, 8 Phase 3, 6 Not applicable, 6 Phase 1.
Follow Pancrelipase: new trials by email Literature Review of Pancrelipase trials Research Report on Pancrelipase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency. NHS7108, Zenpep® - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) | Phase 2 | Recruiting | Aimmune Nestlé Health Science US R&D, LLC | 66 | 2026-10-01 | 2026-10-01 |
| Phase 2 Study to Assess the Safety and Efficacy of ANG003 ANG003 Dose A, ANG003 Dose B, Creon - Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF) | Phase 2 | Recruiting | Anagram Therapeutics, Inc. | 113 | 2026-04-24 | 2026-10-30 |
| Pancrelipase With Nutritional Supplement in Patients at Risk of Malnutrition (EFFORT-ENZO) Zenpep, Placebo - Malnutrition | Not applicable | Recruiting | Philipp Schuetz | 20 | 2025-09-22 | 2026-09-22 |
| Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency Pancrelipase Capsules - Exocrine Pancreatic Insufficiency | Phase 4 | Recruiting | Ohio State University | 30 | 2024-02-01 | 2026-06-10 |
| Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC) Pertzye - Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 17 | 2022-11-30 | 2026-02-25 |
| Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes CREON, Placebo - Type 1 Diabetes | Early Phase 1 | Completed | Vanderbilt University Medical Center | 11 | 2022-09-02 | 2025-03-28 |
| Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon CREON - Cystic Fibrosis, Chronic Pancreatitis | Phase 4 | Completed | AbbVie | 30 | 2021-10-14 | 2024-07-23 |
| Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms CREON - Chronic Pancreatitis | Completed | AbbVie | 63 | 2021-09-16 | 2024-03-28 | |
| Pancreatic Enzymes and Bile Acids in Acutely Ill Severely Malnourished Children Pancreatic Enzyme, Ursodeoxycholic acid, Pancreatic Enzyme placebo - SEPSIS, MALNUTRITION, CHILD | Phase 2 / Phase 3 | Unknown | University of Oxford | 400 | 2021-07-01 | 2023-02-24 |
| Pancreaze (Pancrelipase) for Patients With Pancreatic Adenocarcinoma With Cachexia and Exocrine Pancreatic Insufficiency Pancrelipase - Pancreatic Adenocarcinoma | Phase 2 | Active not recruiting | Andrew Hendifar, MD | 36 | 2020-12-17 | 2026-01-23 |
| Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer CREON - Exocrine Pancreatic Insufficiency (EPI) | Phase 4 | Withdrawn | AbbVie | 2020-05-06 | 2021-11-08 | |
| A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI) Pancrelipase, Placebo - Exocrine Pancreatic Insufficiency (EPI) | Phase 4 | Terminated | AbbVie | 1 | 2020-02-25 | 2023-06-05 |
| A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis Pancrelipase - Cystic Fibrosis | Phase 4 | Completed | AbbVie | 36 | 2019-10-23 | 2023-09-28 |
| Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma Pancrelipase - Pancreatic Cancer | Phase 2 | Terminated | Dana-Farber Cancer Institute | 4 | 2018-04-13 | 2020-08-03 |
| Use of Pancreatic Enzymes in Short Bowel Syndrome Pancreatic Enzyme - Short Bowel Syndrome | Phase 2 | Completed | Children's Hospital of Philadelphia | 16 | 2017-03-24 | 2020-03-20 |
| PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer Pancrelipase, Placebo Oral Capsule - Pancreatic Insufficiency, Pancreatic Cancer | Phase 1 / Phase 2 | Terminated | Massimo Raimondo, M.D. | 16 | 2016-12-01 | 2021-03-15 |
| Fat Malabsorption in Chronic Pancreatitis Creon36™ - Chronic Pancreatitis | Phase 2 | Completed | Children's Hospital of Philadelphia | 48 | 2016-10-13 | 2019-05-03 |
| Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis Pancrelipase, placebo - Pancreatitis | Phase 2 | Withdrawn | Dartmouth-Hitchcock Medical Center | 2016-04-01 | 2018-02-27 | |
| Pancreatic Enzyme Supplementation for Celiac Disease pancrelipase - Celiac Disease | Phase 4 | Terminated | Beth Israel Deaconess Medical Center | 21 | 2015-05-01 | 2021-05-12 |
| Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Creon IR, Creon® (DR/GR) - Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis | Phase 2 | Completed | Abbott | 70 | 2015-03-01 | 2016-04-04 |
Showing 20 of 47. Sign in to see all of them.
Exocrine Pancreatic Insufficiency (30) · Cystic Fibrosis (13) · Pancreatitis, Chronic (9) · Pancreatic Neoplasms (4) · Pancreatitis (3) · Malnutrition (2) · Pancreatic Diseases (2) · Steatorrhea (2) · Abdominal Pain (1) · Celiac Disease (1) · Cerebral Palsy (1) · Child Nutrition Disorders (1) · Diabetes Mellitus, Type 1 (1) · Diarrhea (1) · Digestive System Diseases (1)
AbbVie (6) · Forest Laboratories (6) · Abbott (3) · Digestive Care, Inc. (3) · Children's Hospital of Philadelphia (2) · Abbott Products (1) · Aimmune Nestlé Health Science US R&D, LLC (1) · American Academy of Family Physicians (1) · Anagram Therapeutics, Inc. (1) · Andrew Hendifar, MD (1) · Axcan Pharma (1) · Azidus Brasil (1) · Beth Israel Deaconess Medical Center (1) · Dana-Farber Cancer Institute (1) · Dartmouth-Hitchcock Medical Center (1)
United States (30) · Hungary (4) · Italy (4) · Spain (4) · Bulgaria (3) · Germany (3) · Poland (3) · United Kingdom (3) · France (2) · Bangladesh (1) · Belgium (1) · Brazil (1) · Czechia (1) · Japan (1) · Kenya (1)
Suntje Sander-Struckmeier, PhD (3) · Andrew Hendifar, MD, MPH (1) · Arthur James Moser, MD (1) · Babette Zemel, PhD (1) · Christopher Taylor, MD, PhD (1) · Ciaran Kelly, MD (1) · Craig Peterson (1) · Daniel Moore, MD, PhD (1) · David S Sanders, FRCP (1) · Eileen O'Reilly, MD (1) · Gerard Mullin, MD (1) · Guenter Krause, MD (1)
PMID 32761612, PMID 27013382, PMID 34030986, PMID 35622082, PMID 36687454, PMID 37880023, PMID 42643234
2005 (1), 2009 (1), 2014 (1), 2017 (1), 2025 (1), UL1TR001082 (1)